Search hospitals > Michigan > Detroit
Josephine Ford Cancer Center at Henry Ford Hospital
Claim this profileDetroit, Michigan 48202
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Brain Tumor
Conducts research for Nervous System Tumors
Conducts research for Non-Small Cell Lung Cancer
175 reported clinical trials
9 medical researchers
Summary
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Brain Tumor, Nervous System Tumors, Non-Small Cell Lung Cancer and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 146 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Ding WangHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Non-Small Cell Lung Cancer
49 reported clinical trials
116 drugs studied
Shirish Gadgeel, MDHenry Ford Hospital3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Tumors
17 reported clinical trials
28 drugs studied
Tobias Walbert, MD, PhD, MPHHenry Ford Hospital5 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
12 reported clinical trials
17 drugs studied
Philip Kuriakose, MDHenry Ford Health System3 years of reported clinical research
Studies Hemophilia A
Studies Lymphoma
9 reported clinical trials
13 drugs studied
Clinical Trials running at Josephine Ford Cancer Center at Henry Ford Hospital
Non-Small Cell Lung Cancer
Cancer
Tumors
Solid Tumors
Lung Cancer
Acute Myeloid Leukemia
Metastatic Tumor
Blood Cancers
Prostate Cancer
Neuroendocrine Carcinoma
INBRX-106 + Pembrolizumab
for Lung Cancer
This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and antitumor activity of the combination of INBRX-106 and the anti-PD-1 CPI pembrolizumab (keytruda).
Recruiting1 award Phase 1 & 25 criteria
Adagrasib Combo Therapy
for Lung Cancer
Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with advanced NSCLC with TPS ≥ 1%, TPS \<50% and KRAS G12C mutation
Recruiting1 award Phase 24 criteria
MRT-2359
for Solid Tumors
This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.
Recruiting1 award Phase 1 & 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Josephine Ford Cancer Center at Henry Ford Hospital?
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Brain Tumor, Nervous System Tumors, Non-Small Cell Lung Cancer and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 146 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.